Clinical Trial Update: Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating strategies to prevent clinically apparent rheumatoid arthritis. The study was terminated and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Healthy Participants, Rheumatoid Arthritis (RA) Prevention | Phase 2 | Status: TERMINATED | Results posted: 2023-11-21